Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity

Hepatology

Volumn 48, Issue 6, 2008, Pages 2086-2087

  Emanuele, Enzo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CYTOKERATIN 18; RESISTIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DIAGNOSTIC TEST; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; LETTER; LIVER BIOPSY; LIVER INJURY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; BIOPSY; BLOOD; FATTY LIVER; MASS SCREENING; NOTE; OBESITY; PATHOLOGY; PREDICTION AND FORECASTING;

ADIPONECTIN; BIOLOGICAL MARKERS; BIOPSY; FATTY LIVER; HUMANS; KERATIN-18; MASS SCREENING; OBESITY; PREDICTIVE VALUE OF TESTS; RESISTIN; SENSITIVITY AND SPECIFICITY;

EID: 58149384510     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22622     Document Type: Letter

References (3)

1. Campos GM, Bambha K, Vittinghoff E, Rabl C, Posselt AM, Ciovica R, et al. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. HEPATOLOGY 2008;47:1916-1923.
2. Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008; doi: 10.1007/s11695-008-9506-y
3. Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannagé-Yared MH, et al. Serum proteomic profiling of obese patients: correlation with pathology and evolution after bariatric surgery. Gut 2008; doi: 10.1136/gut.2007.140087